President Joel Breman Among Members Calling For Safe, Quality Medicines During COVID-19

Posted 15 April 2020

ASTMH President Joel G. Breman and other members of ASTMH are among 55 signatories from 20 countries joining the call for urgent efforts to demand safe, quality medicines during the spread of COVID-19. Their comment appeared April 9 on The Lancet website: "Without preparation for the quality assurance of diagnostic tests, drugs, and vaccines, the world risks a parallel pandemic of substandard and falsified products. Interventions are needed globally to ensure access to safe, quality assured, and effective medical products on which the world's population will depend.

Other members include:
 
  • Philip Coyne, Eck Institute For Global Health, University of Notre Dame, Notre Dame, IN, USA 
  • Nicholas Day, MORU Tropical Health Network, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand & Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, UK 
  • Philippe J Guerin, Infectious Diseases Data Observatory, Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, UK 
  • Paul N Newton, Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, UK & Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People’s Democratic Republic & Infectious Diseases Data Observatory, Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, UK & Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK & School of Public Health, Boston University Boston, MA, USA 
  • Nicholas J. White, Mahidol Oxford Tropical Medicine Research Unit, Thailand

Read The Lancet comment article
 
View the list of all 55 signatories